Cipla share price hits record high on DGCI nod to import Moderna vaccine to treat COVID-19; may rally 12% more
Wednesday, June 30, 2021, 5:47
Cipla share price hit a new record high of Rs 997.20 apiece in intraday on BSE on Wednesday, after the DCGI approved the firm to import Moderna, a Covid-19 vaccine, with emergency use authorisation in India.
You can follow any responses to this entry through the
RSS 2.0 feed.